FDA.reportPublic FDA data

Application 212171

Type
ANDA
Sponsor
ZYDUS PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CISATRACURIUM BESYLATECISATRACURIUM BESYLATEINJECTABLE;INJECTIONEQ 2MG BASE/MLNoNo
002CISATRACURIUM BESYLATECISATRACURIUM BESYLATEINJECTABLE;INJECTIONEQ 10MG BASE/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
70710-1532cisatracurium besylatecisatracurium besylateZydus Pharmaceuticals (USA) Inc.ANDACurrent
70710-1532cisatracurium besylatecisatracurium besylateZydus Pharmaceuticals USA Inc.ANDACurrent
70710-1532cisatracurium besylatecisatracurium besylateZydus Pharmaceuticals (USA) Inc.ANDACurrent
70710-1534cisatracurium besylatecisatracurium besylateZydus Pharmaceuticals (USA) Inc.ANDACurrent
70710-1534cisatracurium besylatecisatracurium besylateZydus Pharmaceuticals USA Inc.ANDACurrent
70710-1534cisatracurium besylatecisatracurium besylateZydus Pharmaceuticals (USA) Inc.ANDACurrent
72785-0008cisatracurium besylatecisatracurium besylateCadila Healthcare LimitedANDACurrent
72785-0008cisatracurium besylatecisatracurium besylateZydus Lifesciences LimitedANDACurrent
72785-0008cisatracurium besylatecisatracurium besylateLiva Pharmaceuticals LimitedANDACurrent
72785-0009cisatracurium besylatecisatracurium besylateCadila Healthcare LimitedANDACurrent
72785-0009cisatracurium besylatecisatracurium besylateZydus Lifesciences LimitedANDACurrent
72785-0009cisatracurium besylatecisatracurium besylateLiva Pharmaceuticals LimitedANDACurrent